Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine crossover trial added to standard care for post-traumatic stress disorder
RBR-44msqcsPhase 3Recruiting
- Sponsor
- Universidade Federal da Bahia
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esketamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Universidade Federal da Bahia. Started Sep 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on RBR-44msqcs.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-44msqcs.